Featured Question

How should we educate our patients about the use of immune checkpoint inhibitors—including what to expect from administration and patterns of response to these agents?

See The Answer

Get the latest
science delivered
to your inbox

Answers in CME updates are
available in YOUR specialty.

Sign-up Now!

Featured Activities


Immune Checkpoint Blockade Therapy in Bladder Cancer: Expert Perspectives on Appropriate Patient Selection and Nuances of Clinical Use

Course Director
Elizabeth R. Plimack, MD, MS
Fox Chase Cancer Center,
Temple Health
Philadelphia, Pennsylvania


Challenging Cases in Multiple Sclerosis

Course Director
Aaron E. Miller, MD
Corinne Goldsmith Dickinson Center for Multiple Sclerosis
Mount Sinai School of Medicine
New York, New York